GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk

GSK (GSK.L) has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding the U.S. government and taxpayers by concealing cancer risks in Zantac, once a blockbuster heartburn drug.